ENHO and cardiovascular disorder: Numerous studies indicate that adropin influences cardiovascular system function and participates in the pathogenesis of several cardiovascular diseases (Lovren et al., 2010; Topuz et al., 2013; Wu et al., 2014; Gu et al., 2015; Zhao et al., 2015, 2016; Gulen et al., 2016; Ertem et al., 2017; Oruc et al., 2017; Bolayır et al., 2018; Sato et al., 2018; Altamimi et al., 2019; Thapa et al., 2019b).